Analysis the disease constitution and costs of inpatients in Karamay Central Hospital in 2014_Chinese Journal of Evidence-Based Medicine

Authors：

LIU Yongjiang ¹ , YU Jiajie ² ,  ZHANG Weidong ¹ ,  LI Youping ² , WU Min ¹ , XU Ting ³ , LIU Jianhong ¹ , LU Jing ² , WANG Guotuan ¹ , SUN Xin ² , SU Guanyue ²

1. Department of Pharmacy, Karamay Central Hospital, Karamay, 834000, P.R.China;
2. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
3. Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding?author：

ZHANG Weidong, Email: 0990end@sohu.com.cn; LI Youping, Email: yzmylab@hotmail.com

Keywords：

Karamay Central Hospital; Inpatients; Disease constitution; Costs

DOI：

10.7507/1672-2531.201608041

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate inpatients disease constitution, costs and rational drug use in the Karamay Central Hospital in 2014 and provide baseline data for further evidence-based study. Methods The information of disease classification, single disease drug use and expenditure of inpatients in 2014 were collected from the Hospital Information System (HIS) of Karamay Central Hospital. We classified the diseases according to the international classification of diseases coding (ICD-10), and analyzed the data by Microsoft Excel 2007 software including frequency, proportion, cumulative proportion and sample average. Results ① A total of 24 936 inpatients in 2014 were included, with male to female ratio being 0.96 to 1 and minority rate being 22.95%. The top three systematic diseases were respiratory diseases, diseases concerning pregnancy, child birth and puerperium and circulatory system diseases respectively; ② The top three age groups were 25 to 59, ≥60 and 0 to 4 respectively; ③ The top three costs per capita of single disease were pulmonary infectious, tumor chemotherapy and symptomatic treatment respectively; the top three western medicine costs per capita were tumor chemotherapy, symptomatic treatment and pulmonary infection; the top three Chinese medicine costs per capita were chronic kidney disease (CKD), angina and ischemic stroke. Conclusion The single diseases ranking and percentage of inpatients in 2014 of Karamay Central Hospital were different from the disease burden of Xinjiang Uygur Autonomous Region, the country and even the whole world. Based on the above results, the respiratory diseases and circulatory diseases were selected as the systematic evidence-based pharmacy study goal.

Citation： LIU Yongjiang, YU Jiajie, ZHANG Weidong, LI Youping, WU Min, XU Ting, LIU Jianhong, LU Jing, WANG Guotuan, SUN Xin, SU Guanyue. Analysis the disease constitution and costs of inpatients in Karamay Central Hospital in 2014. Chinese Journal of Evidence-Based Medicine, 2017, 17(4): 373-378. doi: 10.7507/1672-2531.201608041 Copy

1.	克拉瑪依市統計局. 克拉瑪依市 2014 年國民經濟和社會發展統計公報. Available at: .
2.	王莉, 袁強, 李鴻浩, 等. 循證臨床藥學實踐－概念、實踐模式及步驟. 中國循證醫學雜志, 2011, 11(10): 1103-1105.
3.	徐張燕, 張敏, 崔亞萍, 等. 疾病負擔研究的發展與應用. 中國腫瘤, 2013, 22(8): 638-643.
4.	賈惠莉, 楊華, 朱惠. 2013 年新疆某三級綜合醫院住院患者疾病構成分析. 中國衛生統計, 2015, 32(12): 979-983.
5.	郭建新, 張瑞萍. 烏魯木齊市某院 9 524 例老年住院患者疾病構成分析. 數理醫藥雜志, 2012, 25(1): 85-86.
6.	國家衛生和計劃生育委員會. 中國衛生和計劃生育統計年鑒 2015. 北京: 中國協和醫科大學出版社, 2015, 152-155.
7.	馬國芳, 瓦日斯江·阿不都斯木, 楊潔. 2011 年烏魯木齊市某三甲醫院院老年住院患者疾病構成分析. 中國老年學雜志, 2014, 34(1): 471-473.
8.	Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people and implications for health policy and practice. Lancet, 2015, 385(9967): 549-562.
9.	夏擁軍, 韓俊洋, 劉才華, 等. 2010～2013 年新疆某三甲醫院疾病譜分析. 中國病案, 2015, 16(4): 66-69.
10.	李超, 高振, 盧勇. 新疆維吾爾自治區中醫醫院 2008～2010 年度住院疾病構成調查. 中國循證醫學雜志, 2012, 12(4): 420-425.
11.	徐洪元, 賈恩志, 史海龍. 新疆伊犁州 2001 年至 2010 年住院患者疾病譜研究. 中華醫院管理雜志, 2012, 28(4): 277-279.
12.	湯海燕. 2009 年～2013 年某院住院患者疾病構成分析. 中國病案, 2014, 15(8): 61-63.
13.	羅文偉, 張偉雄, 燕花秀. 新疆某縣醫院 2008 年～2012 年住院患者疾病構成分析. 中國病案, 2014, 15(2): 49-51.
14.	Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet, 2012, 380(9859): 2197-2223.
15.	Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the global burden of disease study 2010. Lancet, 2013, 381(9882): 1987-2015.
16.	Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA, 2013, 310(6): 591-608.
17.	Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the global burden of disease study 2010. Lancet, 2012, 380(9859): 2071-2094.
18.	Haro JM, Tyrovolas S, Garin N, et al. The burden of disease in Spain: results from the global burden of disease study 2010. BMC Med, 2014, 12: 236.
19.	Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet, 2016, 387(10015): 251-272.
20.	Global Burden of Disease Pediatrics Collaboration, Kyu HH, Pinho C, et al. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the global burden of disease 2013 study. JAMA Pediatr, 2016, 170(3): 267-287.
21.	Kivim?ki M, Vineis P, Brunner EJ, et al. How can we reduce the global burden of disease? Lancet, 2015, 386(10010): 2235-2237.
22.	Institute for Health Metrics and Evaluation. GBD Compare. Available at: .

1. 克拉瑪依市統計局. 克拉瑪依市 2014 年國民經濟和社會發展統計公報. Available at: .
2. 王莉, 袁強, 李鴻浩, 等. 循證臨床藥學實踐－概念、實踐模式及步驟. 中國循證醫學雜志, 2011, 11(10): 1103-1105.
3. 徐張燕, 張敏, 崔亞萍, 等. 疾病負擔研究的發展與應用. 中國腫瘤, 2013, 22(8): 638-643.
4. 賈惠莉, 楊華, 朱惠. 2013 年新疆某三級綜合醫院住院患者疾病構成分析. 中國衛生統計, 2015, 32(12): 979-983.
5. 郭建新, 張瑞萍. 烏魯木齊市某院 9 524 例老年住院患者疾病構成分析. 數理醫藥雜志, 2012, 25(1): 85-86.
6. 國家衛生和計劃生育委員會. 中國衛生和計劃生育統計年鑒 2015. 北京: 中國協和醫科大學出版社, 2015, 152-155.
7. 馬國芳, 瓦日斯江·阿不都斯木, 楊潔. 2011 年烏魯木齊市某三甲醫院院老年住院患者疾病構成分析. 中國老年學雜志, 2014, 34(1): 471-473.
8. Prince MJ, Wu F, Guo Y, et al. The burden of disease in older people and implications for health policy and practice. Lancet, 2015, 385(9967): 549-562.
9. 夏擁軍, 韓俊洋, 劉才華, 等. 2010～2013 年新疆某三甲醫院疾病譜分析. 中國病案, 2015, 16(4): 66-69.
10. 李超, 高振, 盧勇. 新疆維吾爾自治區中醫醫院 2008～2010 年度住院疾病構成調查. 中國循證醫學雜志, 2012, 12(4): 420-425.
11. 徐洪元, 賈恩志, 史海龍. 新疆伊犁州 2001 年至 2010 年住院患者疾病譜研究. 中華醫院管理雜志, 2012, 28(4): 277-279.
12. 湯海燕. 2009 年～2013 年某院住院患者疾病構成分析. 中國病案, 2014, 15(8): 61-63.
13. 羅文偉, 張偉雄, 燕花秀. 新疆某縣醫院 2008 年～2012 年住院患者疾病構成分析. 中國病案, 2014, 15(2): 49-51.
14. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet, 2012, 380(9859): 2197-2223.
15. Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the global burden of disease study 2010. Lancet, 2013, 381(9882): 1987-2015.
16. Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA, 2013, 310(6): 591-608.
17. Wang H, Dwyer-Lindgren L, Lofgren KT, et al. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the global burden of disease study 2010. Lancet, 2012, 380(9859): 2071-2094.
18. Haro JM, Tyrovolas S, Garin N, et al. The burden of disease in Spain: results from the global burden of disease study 2010. BMC Med, 2014, 12: 236.
19. Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet, 2016, 387(10015): 251-272.
20. Global Burden of Disease Pediatrics Collaboration, Kyu HH, Pinho C, et al. Global and national burden of diseases and injuries among children and adolescents between 1990 and 2013: findings from the global burden of disease 2013 study. JAMA Pediatr, 2016, 170(3): 267-287.
21. Kivim?ki M, Vineis P, Brunner EJ, et al. How can we reduce the global burden of disease? Lancet, 2015, 386(10010): 2235-2237.
22. Institute for Health Metrics and Evaluation. GBD Compare. Available at: .

Next Article
Effects of high dose Ulinastatin with lung protective ventilatory strategies on critical disease patients combined with acute lung injury/acute respiratory distress syndrome

Chinese Journal of Evidence-Based Medicine

Analysis the disease constitution and costs of inpatients in Karamay Central Hospital in 2014

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content